← Back to headlines

Researchers Test Experimental Alzheimer Drug on Pre-Symptomatic Patients
Researchers are shifting their approach to Alzheimer's treatment by testing an experimental medication on individuals who have not yet experienced memory loss, aiming to halt disease progression before clinical symptoms appear.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.


